F77 Antigen Is a Promising Target for Adoptive T Cell Therapy of Prostate Cancer

Scientists entailed the generation and evaluation of a second-generation CAR against a carbohydrate antigen on malignant prostate cancer cells.
[Biochemical And Biophysical Research Communications]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News